MedPath

Ofloxacin

Ofloxacin Otic Solution

Approved
Approval ID

2ec6bd57-96df-47ac-b218-1469801868b7

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 17, 2022

Manufacturers
FDA

Akorn

DUNS: 117696873

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ofloxaxin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50383-025
Application NumberANDA076616
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ofloxaxin
Product Specifications
Route of AdministrationAURICULAR (OTIC)
Effective DateOctober 17, 2022
FDA Product Classification

INGREDIENTS (6)

BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
OFLOXACINActive
Quantity: 3 mg in 1 mL
Code: A4P49JAZ9H
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ofloxacin - FDA Drug Approval Details